IP Library Granted Patent US 11,453,783
Granted Patent B2
US 11,453,783 · App. 17/323,791 · Granted Sep 27, 2022

Polymeric tandem dyes with linker groups

Inventors: Tracy Matray (Snohomish, WA); Sharat Singh (Rancho Santa Fe, CA)
Assignee: Sony Corporation
C09B69/102C07F9/53C07F9/5304C07F9/5329C09B69/105C09B69/109G01N1/30G01N33/582G01N2001/302
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,453,783
App. No.
17/323,791
Granted
Sep 27, 2022
Kind
B2
Abstract

Compounds useful as fluorescent or colored dyes are disclosed. The compounds have the following structure (I): or a stereoisomer, tautomer or salt thereof, wherein R 1 , R 2 , R 3 , R 4 , R 5 , L 1 , L 2 , L 3 , L 4 , M 1 , M 2 , m and n are as defined herein. Methods associated with preparation and use of such compounds is also provided.

Claims (79)

1. A compound having the following structure (I):

or a stereoisomer, salt or tautomer thereof, wherein:

M 1 and M 2 are, at each occurrence, independently a fluorescent or colored chromophore, provided that at least one of M 1 and M 2 is a FRET donor, and another one of M 1 and M 2 is a corresponding FRET acceptor, at least one of the FRET donor chromophores is positioned between two FRET acceptor chromophores, and at least one occurrence of M 1 and M 2 are different chromophores selected such that M 1 and M 2 form a FRET pair;

L 1 is, at each occurrence, independently an optional alkylene or heteroalkylene linker;

L 2 and L 3 are, at each occurrence, independently an optional alkylene, alkenylene, alkynylene, heteroalkylene, heteroalkenylene, heteroalkynylene or heteroatomic linker;

L 4 is, at each occurrence, independently an alkylene or heteroalkylene linker;

R 1 is, at each occurrence, independently H, alkyl or alkoxy;

R 2 and R 3 are each independently H, OH, SH, alkyl, alkoxy, alkylether, heteroalkyl, —OP(═R a )(Rdb)R c , Q, or a protected form thereof, or L′;

R 4 is, at each occurrence, independently OH, SH, O − , S − , OR d or SR d ;

R 5 is, at each occurrence, independently oxo, thioxo or absent;

R a is O or S;

R b is OH, SH, O − , S − , OR d or SR d ;

R c is OH, SH, O − , S − , OR d , OL′, SR d , alkyl, alkoxy, heteroalkyl, heteroalkoxy, alkylether, alkoxyalkylether, phosphate, thiophosphate, phosphoalkyl, thiophosphoalkyl, phosphoalkylether or thiophosphoalkylether;

R d is a counter ion;

Q is, at each occurrence, independently a moiety comprising a reactive group, or protected form thereof, capable of forming a covalent bond with an analyte molecule, a targeting moiety, a solid support or a complementary reactive group Q;

L′ is, at each occurrence, independently a linker comprising a covalent bond to Q, a linker comprising a covalent bond to a targeting moiety, a linker comprising a covalent bond to an analyte molecule, a linker comprising a covalent bond to a solid support, a linker comprising a covalent bond to a solid support residue, a linker comprising a covalent bond to a nucleoside or a linker comprising a covalent bond to a further compound of structure (I);

m is, at each occurrence, independently an integer of zero or greater; and

n is an integer of two or greater,

provided that at least one occurrence of L 4 is heteroalkylene or at least one occurrence of m is 0 when M 1 and M 2 are selected from fluorescein, pyrene and perylene chromophores.

2. The compound of claim 1 , wherein the compound has the following structure (IA):

wherein:

z is, at each occurrence, independently an integer from 1 to 100; and

m 1 , m 2 and m 3 are, at each occurrence, independently an integer from 0 to 6.

3. The compound of claim 1 , wherein the compound has the following structure (IB):

wherein:

z is, at each occurrence, independently an integer from 1 to 100.

4. The compound of claim 1 , wherein the compound has the following structure (IC):

wherein:

x 1 , x 2 , x 3 and x 4 are, at each occurrence, independently an integer from 0 to 6.

5. The compound of claim 2 , wherein the compound has the following structure (ID):

6. The compound of claim 1 , wherein the compound has the following structure (IE):

7. A compound having the following structure (II):

or a stereoisomer, salt or tautomer thereof, wherein:

M 1 and M 2 are, at each occurrence, independently a fluorescent or colored chromophore, provided that at least one occurrence of M 1 and M 2 are different chromophores, at least one occurrence of M 1 and M 2 combine to form a FRET acceptor-donor pair, and the FRET donor chromophore in the FRET acceptor-donor pair is positioned between two FRET acceptor chromophores;

L 1 is at each occurrence, independently an optional alkylene or heteroalkylene linker;

L 2 and L 3 are, at each occurrence, independently an optional alkylene, alkenylene, alkynylene, heteroalkylene, heteroalkenylene, heteroalkynylene or heteroatomic linker;

L 4 is, at each occurrence, independently an alkylene or heteroalkylene linker;

R 1 is, at each occurrence, independently H, alkyl or alkoxy;

R 2 and R 3 are each independently H, OH, SH, alkyl, alkoxy, alkylether, heteroalkyl, —OP(═R a )(R b )R c , Q, or a protected form thereof, or L′;

R 4 is, at each occurrence, independently OH, SH, O − , S − , OR d or SR d ;

R 5 is, at each occurrence, independently oxo, thioxo or absent;

R a is O or S;

R b is OH, SH, O − , S − , OR d or SR d ;

R c is OH, SH, O − , S − , OR d , OL′, SR d , alkyl, alkoxy, heteroalkyl, heteroalkoxy, alkylether, alkoxyalkylether, phosphate, thiophosphate, phosphoalkyl, thiophosphoalkyl, phosphoalkylether or thiophosphoalkylether;

R d is a counter ion;

Q is, at each occurrence, independently a moiety comprising a reactive group, or protected form thereof, capable of forming a covalent bond with an analyte molecule, a targeting moiety, a solid support or a complementary reactive group Q′;

L′ is, at each occurrence, independently a linker comprising a covalent bond to Q, a linker comprising a covalent bond to a targeting moiety, a linker comprising a covalent bond to an analyte molecule, a linker comprising a covalent bond to a solid support, a linker comprising a covalent bond to a solid support residue, a linker comprising a covalent bond to a nucleoside or a linker comprising a covalent bond to a further compound of structure (II);

m is, at each occurrence, independently an integer of zero to two or greater than 6; and

n is an integer of two or greater.

8. The compound of claim 1 , wherein L 1 has one of the following structures:

wherein

a, b, and c are each independently an integer ranging from 1-6.

9. The compound of claim 1 , wherein R 4 is, at each occurrence, independently OH, O − or OR d , R 5 is, at each occurrence, oxo, and R 1 is, at each occurrence, H.

10. The compound of claim 1 , wherein R 2 and R 3 are each independently —OP(═R a )(R b )R c .

11. The compound of claim 10 , wherein R c is OL′.

12. The compound of claim 11 , wherein L′ is a heteroalkylene linker to: Q, a targeting moiety, an analyte molecule, a solid support, a solid support residue, a nucleoside or a further compound of structure (I).

13. The compound of claim 12 , wherein L′ comprises an alkylene oxide or phosphodiester moiety, or combinations thereof.

14. The compound of claim 11 , wherein L′ has the following structure:

wherein:

m″ and n″ are independently an integer from 1 to 10;

R e is H, an electron pair or a counter ion;

L″ is R e or a direct bond or linkage to: Q, a targeting moiety, an analyte molecule, a solid support, a solid support residue, a nucleoside or a further compound of structure (I).

15. The compound of claim 1 , wherein Q comprises a sulfhydryl, disulfide, activated ester, isothiocyanate, azide, alkyne, alkene, diene, dienophile, acid halide, sulfonyl halide, phosphine, α-haloamide, biotin, amino or maleimide functional group.

16. The compound of claim 1 , wherein Q has one of the following structures:

wherein each X is independently a halogen.

17. The compound of claim 1 , wherein R 2 or R 3 has one of the following structures:

18. The compound of claim 1 , wherein M 1 and M 2 at each occurrence, independently have one of the following structures:

19. The compound of claim 1 , wherein the compound has one of the following structures:

wherein HEG, R 3 , dT, B, B′, C, F, T and Y have the following structures, respectively:

20. The compound of claim 7 , wherein the compound has one of the following structures:

wherein F and Y have the following structures, respectively:

21. A method of staining a sample, comprising adding to said sample the compound of claim 1 in an amount sufficient to produce an optical response when said sample is illuminated at an appropriate wavelength.

22. A method for visually detecting an analyte molecule, the method comprising:

(a) providing the polymer compound of claim 1 , wherein the polymer compound comprises a covalent bond to the analyte molecule; and

(b) detecting the polymer compound by its visible properties.

23. A method for visually detecting an analyte molecule, the method comprising:

(a) ad-mixing the polymer compound of claim 1 , wherein the polymer compound comprises a covalent bond to Q, with the analyte molecule;

(b) forming a bio-conjugate of the polymer compound and the analyte molecule; and

(c) detecting the bio-conjugate by its visible properties.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 28, 2024
From: MATRAY, TRACY; SINGH, SHARAT
To: SONY CORPORATION; SONY CORPORATION OF AMERICA
Reel/Frame 067540/0980 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 28, 2024
From: SONY CORPORATION OF AMERICA
To: SONY CORPORATION
Reel/Frame 067541/0214 →
CHANGE OF NAME Recorded May 28, 2024
From: SONY CORPORATION
To: SONY GROUP CORPORATION
Reel/Frame 067552/0921 →
Continuity (3)
Continuation 16982355
Provisional Application 62646234 · Mar 21, 2018
Related Publication 20210340380A1 · Nov 4, 2021
Cited By (15)
US 12,194,104 US 12,270,812 US 12,275,851 US 12,290,571 US 12,319,817 US 12,359,071 US 12,391,833 US 12,461,106 US 12,473,433 US 12,539,334 US 12,560,612 US 12,577,403 US 12,578,342 US 12,606,588 US 12,629,425